Urethral insert for treatment of erectile dysfunction
AssigneeAlza Corporation
InventorsVirgil A. Place, Robert M. Gale, Randall G. Berggren
Life of this patent
Estimating the term…
Abstract
Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (1) having a rapidly releasing coating (4) containing the agent on its exterior surface or by means of an inserter (27) carrying an agent containing dose of agent (31) which can be displaced into the urethra.
Claims13
A dosage form for administering a therapeutic agent to the urethra, said dosage form comprising an insert component received within a container component, wherein:
- a) said insert component comprises
- (i) a shaft portion sized to be received within the urethra;
- (ii) a plug attached to said shaft portion portion having a dimension greater than the diameter of the urethra to prevent complete insertion of said insert into the urethra;
- and
- (iii) a dose containing a therapeutic amount of said agent, said dose being carried in its entirety by said shaft;
- and
- b) said container component is closed at one end, open at the other end and of sufficient length to receive said shaft and at least a portion of said plug, the open end of said container being sized to form a sliding seal with said plug.
Dependencies are inferred from the claim text.